Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 16, 2022
Catalent announced that it is to establish a new biologics analytical center of excellence in Durham, within North Carolina’s Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, ...
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more
Tuesday, December 20, 2022
The U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an outsourcing facility with a history of violations.
read more
Tuesday, December 20, 2022
Scorpion Biological Services has changed its name to Scorpius BioManufacturing to reflect the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
read more
Wednesday, January 04, 2023
MA–Nova Biomedical is pleased to announce the launch of BioProfile FAST CDVTM, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100uL of sample volume. In ...
read more
Thursday, January 05, 2023
Verrica Pharmaceuticals Inc. announced the successful completion of the technology transfer of bulk solution manufacturing to Piramal Pharma Solutions.
read more
Thursday, January 05, 2023
AmerisourceBergen Corporation announced the completion of its acquisition of PharmaLex Holding GmbH.
read more
X-Chem announced the establishment of a research partnership with Sironax, in which X-Chem will leverage its powerful DEL platform to support Sironax’s drug discovery pipeline.
read more
Paratek Pharmaceuticals, Inc. announced the receipt of a $36.4 million milestone payment associated with the second procurement of NUZYRA® (omadacycline) under the company’s Project BioShield contract with the Biomedical Advanced Research and ...
read more
Tuesday, January 10, 2023
Avantor, Inc. has entered into a multi-year supply and services agreement with Catalent, Inc. enabling the development and supply of better treatments for patients worldwide.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce an Irradiate to Order service for its single-use bioprocess component portfolio.
read more
Thursday, January 12, 2023
Argonaut Manufacturing Services announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.
read more
Thursday, January 12, 2023
lora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in Fort Worth, TX.
read more
Thursday, January 12, 2023
Charles River Laboratories International, Inc. announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract development and manufacturing (CDMO) and biologics testing experience.
read more